Delivery Order SPE2DB20D3101-SPE2DB25FRQV7
- Not listed
- The Defense Logistics Agency awarded a $6,788.95 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $9,922.90 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment of medical supply needs through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors valued at $1,031.20 under a firm fixed price contract. This non-set-aside award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,188.74. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.44 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a $14,958.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 21, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management within military and federal healthcare...
- The Defense Logistics Agency awarded a $1,304.80 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Dexcom G6 Sensor 3S continuous glucose monitoring devices. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of July 22, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- This is a $1,535.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for DEXCOM G7 SENSORS. The contract has an ultimate completion date of May 30, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides comprehensive global pharmaceutical support to military...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRQV7Delivery Order
The Defense Logistics Agency awarded a $5,405.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates its capability to deliver a wide range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Dexcom G7 sensors procurement aligns with the Defense Health Agency's medical supply requirements and reflects AmerisourceBergen's established position as a competitive, reliable vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/22/25 |